The influence of ionic strength on the interaction of quaternary drugs with mammalian acetylcholinesterase in relation to possible regulatory effects.
D000110:Acetylcholinesterase / Q000032:analysis; D000818:Animals; D001921:Brain / Q000201:enzymology; D002118:Calcium / Q000378:metabolism; D002845:Chromatography; D004347:Drug Interactions; D004912:Erythrocytes / Q000201:enzymology; D005703:Gallamine Triethiodide / Q000494:pharmacology*; D066298:In Vitro Techniques; D008094:Lithium / Q000494:pharmacology; D008274:Magnesium / Q000378:metabolism; D008722:Methods; D009994:Osmolar Concentration; D011188:Potassium / Q000494:pharmacology; D011220:Pralidoxime Compounds / Q000494:pharmacology*; D051381:Rats; D012413:Rubidium / Q000494:pharmacology; D012965:Sodium Chloride / Q000008:administration & dosage / Q000494:pharmacology; D013324:Strontium / Q000378:metabolism; D014403:Tubocurarine / Q000494:pharmacology*
D011220:Pralidoxime Compounds; D012965:Sodium Chloride; D008094:Lithium; D000110:Acetylcholinesterase; D008274:Magnesium; D012413:Rubidium; D005703:Gallamine Triethiodide; D011188:Potassium; D002118:Calcium; D014403:Tubocurarine; D013324:Strontium